Carson Wealth (CWM LLC)’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
DCM
ACA
DTC
OCA
CC
Carson Wealth (CWM LLC)'s DFTX Position: Q1 2026 in Review
Carson Wealth (CWM LLC) increased its Definium Therapeutics (DFTX) stake by 4.6% in Q1 2026, buying an estimated $4.21K and bringing the position to 5,600 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #3217.
Carson Wealth (CWM LLC) first reported a position in DFTX in Q2 2021 and has held it in 18 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.
- Carson Wealth (CWM LLC) held 5,600 shares of Definium Therapeutics worth $106K as of Q1 2026.
- Carson Wealth (CWM LLC) bought 248 Definium Therapeutics shares in Q1 2026, an estimated $4.21K.
- Definium Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3217 holding.
- Carson Wealth (CWM LLC) first reported a position in Definium Therapeutics in Q2 2021 and has held it in 18 quarters since.
- 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.